COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment.


Journal

Journal of neuroimmunology
ISSN: 1872-8421
Titre abrégé: J Neuroimmunol
Pays: Netherlands
ID NLM: 8109498

Informations de publication

Date de publication:
15 12 2020
Historique:
received: 27 08 2020
revised: 17 09 2020
accepted: 18 09 2020
pubmed: 9 10 2020
medline: 15 12 2020
entrez: 8 10 2020
Statut: ppublish

Résumé

Encephalopathy is emerging as a recurrent complication of COVID-19 yet remains poorly characterized. We report the case of a middle-aged woman with COVID-19-related encephalopathy presenting as expressive aphasia and inattentiveness, subsequently progressing to agitation and marked confusion. Brain MRI and CSF analysis were unremarkable, while EEG showed slowing with frontal sharp waves. Neuropsychiatric symptoms resolved following treatment with tocilizumab. CNS involvement in COVID-19 may present as a subacute encephalopathy characterized by prominent frontal lobe dysfunction, with language disturbances as first neurological manifestation. Future studies should further investigate the role of tocilizumab in treating COVID-19-related encephalopathy.

Identifiants

pubmed: 33032013
pii: S0165-5728(20)30583-X
doi: 10.1016/j.jneuroim.2020.577400
pmc: PMC7513756
pii:
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
tocilizumab I031V2H011

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

577400

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Références

Eur J Neurol. 2020 Sep;27(9):e43-e44
pubmed: 32383343
Epilepsia Open. 2020 May 17;5(2):314-324
pubmed: 32537529
Ann Neurol. 2020 Aug;88(2):423-427
pubmed: 32418288
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Science. 2020 May 1;368(6490):473-474
pubmed: 32303591
BMC Neurol. 2020 Jun 18;20(1):248
pubmed: 32552792
Clin Neurophysiol. 2020 Sep;131(9):2265-2267
pubmed: 32736327
Gen Hosp Psychiatry. 2020 Jul - Aug;65:47-53
pubmed: 32470824
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Ann Neurol. 2020 Oct;88(4):860-861
pubmed: 32715524
Ann Neurol. 2020 Jul;88(1):1-11
pubmed: 32506549
Chest. 2020 Oct;158(4):1397-1408
pubmed: 32553536
J Neurol. 2020 Jul 11;:
pubmed: 32654063
Epilepsia. 2020 Aug;61(8):e90-e94
pubmed: 32589794
Blood. 2008 Nov 15;112(10):3959-64
pubmed: 18784373
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10970-10975
pubmed: 32350134

Auteurs

Lorenzo Muccioli (L)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.

Umberto Pensato (U)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.

Ilaria Cani (I)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy.

Luca Guerra (L)

Infectious Diseases Unit, AOSP and AUSL Bologna, Bologna, Italy.

Federica Provini (F)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; IRCCS Istituto delle Scienze Neurologiche di Bologna, Full Member of the ERN EpiCARE, Bologna, Italy.

Giorgio Bordin (G)

Piccole Figlie Hospital, Parma, Italy.

Luca Albini Riccioli (LA)

IRCCS Istituto delle Scienze Neurologiche di Bologna, Full Member of the ERN EpiCARE, Bologna, Italy.

Raffaele Lodi (R)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; IRCCS Istituto delle Scienze Neurologiche di Bologna, Full Member of the ERN EpiCARE, Bologna, Italy.

Paolo Tinuper (P)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; IRCCS Istituto delle Scienze Neurologiche di Bologna, Full Member of the ERN EpiCARE, Bologna, Italy.

Francesca Bisulli (F)

Department of Biomedical and NeuroMotor Sciences, University of Bologna, Bologna, Italy; IRCCS Istituto delle Scienze Neurologiche di Bologna, Full Member of the ERN EpiCARE, Bologna, Italy. Electronic address: francesca.bisulli@unibo.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH